Tag Archives: schizophrenia

Stop the Stigma of Mental Illness? Try Stopping the Pharma Funded Campaigns & Groups Behind the “Stigmatizing”

With a seemingly altruistic agenda, the fact is the campaign to end the “stigma” of mental illness is one driven and funded by pharma, psychiatry and pharmaceutical front groups such as NAMI and CHADD to name but a few. For example, take NAMI’s campaign to stop the “stigma” and “end discrimination” against the mentally ill—the “Founding Sponsors” were Abbott Labs, Bristol-Myers Squibb, Eli Lilly, Janssen, Pfizer, Novartis, SmithKline Beecham and Wyeth-Ayerst Labs.

Hundreds of U.S. Pilots Treated for Drug Abuse and Psychiatric Disorders, Review Finds

Hundreds of commercial and private U.S. pilots have been diagnosed and treated for a broad array of serious psychiatric and medical conditions, including schizophrenia, attempted suicide, sexual deviance, alcoholism and drug abuse, a Herald review has found.

Americas Mental Illness Epidemic

Tens of millions of innocent, unsuspecting Americans, who are mired deeply in the mental “health” system, have actually been made crazy by the use of or the withdrawal from commonly-prescribed, brain-altering, brain-disabling, indeed brain-damaging psychiatric drugs that have been, for many decades, cavalierly handed out like candy often in untested and therefore unapproved combinations of drugs – to trusting and unaware patients by equally unaware but well-intentioned physicians who have been under the mesmerizing influence of slick and obscenely profitable psychopharmaceutical drug companies aka, BigPharma.

New Jersey Is Sued Over the Forced Medication of Patients at Psychiatric Hospitals

Patient advocates filed a federal lawsuit on Tuesday charging that New Jersey psychiatric hospitals routinely medicate patients against their will without a review by an outside arbiter, a practice that is banned in most other states.

Science Mag—This Is Your Brain Off Drugs:Why Pharma May Be Cooling on Psychiatry Drugs—no pathology for mental ‘disease’

Earlier this year, pharmaceutical giant AstraZeneca announced it was ceasing drug-discovery research for psychiatric disorders such as depression and schizophrenia…”Basically, from a research perspective, we’re pulling out of the psychiatry space.”— neuroscientist Menelas Pangalos